Cargando…

Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC

BACKGROUND: Recently, several studies have reported that dedifferentiation occurs in fatal well-differentiated thyroid cancer (WDTC) cases. This study aimed at investigating the clinicopathological characteristics of WDTC undergoing dedifferentiation. METHODS: A total of 63 WDTC patients harboring d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ben, Xu, Weibo, Wei, Wenjun, Wen, Duo, Lu, Zhongwu, Yang, Shuwen, Chen, Tongzhen, Wang, Yulong, Wang, Yu, Ji, Qinghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987325/ https://www.ncbi.nlm.nih.gov/pubmed/29951093 http://dx.doi.org/10.1155/2018/2383715

Ejemplares similares

The impact of presence of Hashimoto's thyroiditis on diagnostic accuracy of ultrasound‐guided fine‐needle aspiration biopsy in subcentimeter thyroid nodules: A retrospective study from FUSCC
por: Gao, Lili, et al.
Publicado: (2017)

Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer
por: Xu, Weibo, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer
por: Wen, Shishuai, et al.
Publicado: (2021)

A Comparison of Two Operation Methods Revealed the Risk Factors and the Necessity of LN-prRLN Dissection in Papillary Thyroid Carcinoma: A Retrospective Cohort Study in FUSCC
por: Wang, Yunjun, et al.
Publicado: (2020)

Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC
por: Zheng, Shuyue, et al.
Publicado: (2022)

TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis
por: Yu, Pengcheng, et al.
Publicado: (2023)

Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases
por: Cao, Lei, et al.
Publicado: (2021)

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2016)

Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma
por: Yang, Shuwen, et al.
Publicado: (2022)

Corrigendum: Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2017)

Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases
por: Yiğit, Seyran, et al.
Publicado: (2018)

Integrated proteogenomic characterization of medullary thyroid carcinoma
por: Shi, Xiao, et al.
Publicado: (2022)

Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022)

Warthin Tumor-Like Papillary Thyroid Carcinoma with a Minor Dedifferentiated Component: Report of a Case with Clinicopathologic Considerations
por: Amico, Paolo, et al.
Publicado: (2010)

DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2016)

New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Characterizing dedifferentiation of thyroid cancer by integrated analysis
por: Luo, Han, et al.
Publicado: (2021)

Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
por: Shang, Hongxia, et al.
Publicado: (2019)

Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
por: Wang, Xuemin, et al.
Publicado: (2021)

Apoptosis Activation in Thyroid Cancer Cells by Jatrorrhizine-Platinum(II) Complex via Downregulation of PI3K/AKT/Mammalian Target of Rapamycin (mTOR) Pathway
por: Lu, KeBin, et al.
Publicado: (2020)

New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer
por: Antonelli, Alessandro, et al.
Publicado: (2010)

Dedifferentiated liposarcoma of the thyroid gland: A case report
por: Kishimoto, Yo, et al.
Publicado: (2019)

Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
por: McGovern, Yevette, et al.
Publicado: (2017)

Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations
por: Codenotti, Silvia, et al.
Publicado: (2019)

Dedifferentiated Endometrioid Carcinomas with Neuroendocrine Differentiation: A Clinicopathological and Immunohistochemical Study of Three Cases
por: Zhou, Feng, et al.
Publicado: (2020)

Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery
por: Hu, Jin, et al.
Publicado: (2022)

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)

Metastatic Dedifferentiated Chondrosarcoma to Thyroid Gland: A Case Report
por: Aladily, Tariq N., et al.
Publicado: (2021)

ODP497 Multifocal Papillary Thyroid Carcinoma with Anaplastic Dedifferentiation
por: Jacinto, Jorg Jurgen N, et al.
Publicado: (2022)

Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue
por: Kloth, Lars, et al.
Publicado: (2011)

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014)

Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma
por: Tseng, William W., et al.
Publicado: (2015)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
por: De Vita, Alessandro, et al.
Publicado: (2016)

Frequent amplification of receptor tyrosine kinase genes in well-differentiated/ dedifferentiated liposarcoma
por: Asano, Naofumi, et al.
Publicado: (2017)

Mass dedifferentiation
por: LeBrasseur, Nicole
Publicado: (2004)

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)

SUN-612 Pleural Effusions Revealing Anaplastic Dedifferentiation of Papillary Thyroid Carcinoma
por: Hussain, Qudsia, et al.
Publicado: (2019)

Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors
por: Peng, Tingsheng, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ik3nv28bpm7n9o0544qgpvcb1i